StemTek is a biopharmaceutical company founded in 2013, dedicated to the development of new drugs against cancer, directed against the cells responsible for tumor growth and relapse (tumor stem cells).
The goal of StemTek is to break the barriers of drug development in Oncology to develop new more effective treatments.
StemTek uses the innovative 3D cell culture technology to find new, more effective anti-cancer drugs, replicating the natural growth of the tumor.